Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Colorectal Neoplasms

  Free Subscription


01.10.2018

1 Ann Oncol
1 Ann Surg Oncol
1 BMC Cancer
1 BMC Gastroenterol
1 Cancer Lett
1 Eur J Cancer
2 Eur J Surg Oncol
1 Gastroenterology
1 Gut
1 Int J Cancer
2 J Surg Oncol
1 Lancet
2 Lancet Gastroenterol Hepatol
1 Oncol Rep
1 Oncology (Williston Park)
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Oncol

  1. MOOI JK, Wirapati P, Asher R, Lee CK, et al
    The prognostic impact of Consensus Molecular Subtypes (CMS) and its predictive effects for bevacizumab benefit in metastatic colorectal cancer: molecular analysis of the AGITG MAX clinical trial.
    Ann Oncol. 2018 Sep 21. pii: 5104878. doi: 10.1093.
    PubMed     Text format     Abstract available


    Ann Surg Oncol

  2. WEERINK LBM, Gant CM, van Leeuwen BL, de Bock GH, et al
    Long-Term Survival in Octogenarians After Surgical Treatment for Colorectal Cancer: Prevention of Postoperative Complications is Key.
    Ann Surg Oncol. 2018 Sep 22. pii: 10.1245/s10434-018-6766.
    PubMed     Text format     Abstract available


    BMC Cancer

  3. YANG L, Xiong Z, Xie QK, He W, et al
    Second primary colorectal cancer after the initial primary colorectal cancer.
    BMC Cancer. 2018;18:931.
    PubMed     Text format     Abstract available


    BMC Gastroenterol

  4. KIM J, Kim JH, Lee JY, Chun J, et al
    Clinical outcomes of endoscopic mucosal resection for rectal neuroendocrine tumor.
    BMC Gastroenterol. 2018;18:77.
    PubMed     Text format     Abstract available


    Cancer Lett

  5. WANG S, Xiao Z, Hong Z, Jiao H, et al
    FOXF1 promotes angiogenesis and accelerates bevacizumab resistance in colorectal cancer by transcriptionally activating VEGFA.
    Cancer Lett. 2018 Sep 22. pii: S0304-3835(18)30591.
    PubMed     Text format     Abstract available


    Eur J Cancer

  6. GOOTJES EC, Bakkerus L, Ten Tije AJ, Witteveen PO, et al
    The value of tumour debulking for patients with extensive multi-organ metastatic colorectal cancer.
    Eur J Cancer. 2018;103:160-164.
    PubMed     Text format     Abstract available


    Eur J Surg Oncol

  7. HANGAARD HANSEN C, Gogenur M, Tvilling Madsen M, Gogenur I, et al
    The effect of time from diagnosis to surgery on oncological outcomes in patients undergoing surgery for colon cancer: A systematic review.
    Eur J Surg Oncol. 2018;44:1479-1485.
    PubMed     Text format     Abstract available

  8. BREUGOM AJ, Bastiaannet E, Dekker JWT, Wouters MWJM, et al
    Decrease in 30-day and one-year mortality over time in patients aged >/=75 years with stage I-III colon cancer: A population-based study.
    Eur J Surg Oncol. 2018 Aug 29. pii: S0748-7983(18)31284.
    PubMed     Text format     Abstract available


    Gastroenterology

  9. MACFARLAND SP, Zelley K, Long JM, McKenna D, et al
    Earlier colorectal cancer screening may be necessary in patients with Li-Fraumeni Syndrome.
    Gastroenterology. 2018 Sep 19. pii: S0016-5085(18)35028.
    PubMed     Text format    


    Gut

  10. GUDRA D, Shoaie S, Fridmanis D, Klovins J, et al
    A widely used sampling device in colorectal cancer screening programmes allows for large-scale microbiome studies.
    Gut. 2018 Sep 21. pii: gutjnl-2018-316225. doi: 10.1136/gutjnl-2018-316225.
    PubMed     Text format    


    Int J Cancer

  11. BORMANN F, Stinzing S, Tierling S, Morkel M, et al
    Epigenetic regulation of Amphiregulin and Epiregulin in colorectal cancer.
    Int J Cancer. 2018 Sep 25. doi: 10.1002/ijc.31892.
    PubMed     Text format     Abstract available


    J Surg Oncol

  12. MARGONIS GA, Buettner S, Andreatos N, Wagner D, et al
    The prognosis of colorectal cancer liver metastases associated with inflammatory bowel disease: An exploratory analysis.
    J Surg Oncol. 2018 Sep 27. doi: 10.1002/jso.25251.
    PubMed     Text format     Abstract available

  13. WATANABE A, Harimoto N, Araki K, Yoshizumi T, et al
    A new strategy based on fluorodeoxyglucose-positron emission tomography for managing liver metastasis from colorectal cancer.
    J Surg Oncol. 2018 Sep 27. doi: 10.1002/jso.25250.
    PubMed     Text format     Abstract available


    Lancet

  14. ROTHWELL PM, Cook NR, Gaziano JM, Price JF, et al
    Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials.
    Lancet. 2018;392:387-399.
    PubMed     Text format     Abstract available


    Lancet Gastroenterol Hepatol

  15. ROMERA A, Peredpaya S, Shparyk Y, Bondarenko I, et al
    Bevacizumab biosimilar BEVZ92 versus reference bevacizumab in combination with FOLFOX or FOLFIRI as first-line treatment for metastatic colorectal cancer: a multicentre, open-label, randomised controlled trial.
    Lancet Gastroenterol Hepatol. 2018 Sep 24. pii: S2468-1253(18)30269.
    PubMed     Text format     Abstract available

  16. VLEUGELS JLA, Rutter MD, Ragunath K, Rees CJ, et al
    Chromoendoscopy versus autofluorescence imaging for neoplasia detection in patients with longstanding ulcerative colitis (FIND-UC): an international, multicentre, randomised controlled trial.
    Lancet Gastroenterol Hepatol. 2018 Mar 19. pii: S2468-1253(18)30055.
    PubMed     Text format     Abstract available


    Oncol Rep

  17. BI C, Jiang B
    Downregulation of RPN2 induces apoptosis and inhibits migration and invasion in colon carcinoma.
    Oncol Rep. 2018;40:283-293.
    PubMed     Text format     Abstract available


    Oncology (Williston Park)

  18. LEE JJ, Chu E
    The Adjuvant Treatment of Stage III Colon Cancer: Might Less Be More?
    Oncology (Williston Park). 2018;32.
    PubMed     Text format     Abstract available


    PLoS One

  19. SEO MK, Cairns J
    Do cancer biomarkers make targeted therapies cost-effective? A systematic review in metastatic colorectal cancer.
    PLoS One. 2018;13:e0204496.
    PubMed     Text format     Abstract available

  20. MARTIN-MORALES L, Rofes P, Diaz-Rubio E, Llovet P, et al
    Novel genetic mutations detected by multigene panel are associated with hereditary colorectal cancer predisposition.
    PLoS One. 2018;13:e0203885.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: